Telephone: +61 3 9320 9555|

clinical trials

/Tag:clinical trials

FDA Approves Drug for Treatment of DMD

By | April 3rd, 2017|information, research, trials|

Chantal Coles PhD NMDRC provides a Research Update... On September 19th last year the U.S Food and Drug Administration (FDA) approved the first [...]

Dr Jason White – Back in the Lab

By | March 29th, 2017|information, research|

Recently, Dr. Jason White, lead researcher at the National Muscular Dystrophy Research Centre (NDMRC) at the Murdoch Children’s Research Institute, returned from six [...]

Spinal Muscular Atrophy (SMA) Research Update

By | November 17th, 2016|atrophies, research, trials|

Spinal Muscular Atrophy (SMA) Research update and treatment - AUSTRALIA A research update by Prof. Monique Ryan Director, Department of Neurology Group Leader, [...]

Muscle Clinic

By | October 24th, 2016|

Muscle Clinic A world-first initiative, the MDA funded (we have invested in excess of $1.5 million) clinic is an initiative in which we [...]

Respiratory Care in MD

By | July 23rd, 2016|

Respiratory care and ventilation There are many different neuromuscular conditions in which weakness of the breathing muscles requires monitoring and treatment and may [...]

Percutaneous Endoscopic Gastrostomy (PEG)

By | July 23rd, 2016|

Definition A surgical procedure to place a tube inside of the stomach. Involvement Stomach, skin, parts of the abdominal wall. Reasons for Procedure [...]

Clinical trial for Congenital MD

By | July 23rd, 2016|

Swiss pharmaceutical company Santhera has announced that it will soon start a clinical trial of a drug called omigapil in children with congenital [...]

Clinical trial of new steroid for DMD

By | July 23rd, 2016|

ReveraGen BioPharma has announced the start of a Phase 1 clinical trial of a new steroidal drug, VBP15, for Duchenne muscular dystrophy (DMD). [...]

Ataluren trial for Duchenne MD in Europe

By | July 23rd, 2016|

Ataluren is set to be the first ever drug licenced to treat the underlying genetic cause of Duchenne muscular dystrophy (MD). The European [...]

DMD clinical trial update drisapersen

By | July 23rd, 2016|

drisapersen might work after all At the end of 2013 devastating news was announced – the phase 3 clinical trial conducted by GlaxoSmithKline [...]